USE OF A MILK PROTEIN HYDROLYSATE IN THE TREATMENT OF DIABETES
摘要
Use of a milk protein hydrolysate which is preferably a whey protein hydrolysate or caseinoglycomacropeptide (CGMP) in a bioavailable form in the manufacture of a composition for the treatment or prevention of diabetes or syndrome X and a method of treatment or prevention of diabetes or syndrome X are described. The present invention also relates to a method for assessing proglucagon gene expression and GLP-1 release by a cell line derived from an adenocarcinoma of human caecum.
申请公布号
WO0137850(A3)
申请公布日期
2002.01.10
申请号
WO2000EP10716
申请日期
2000.10.27
申请人
SOCIETE DES PRODUITS NESTLE S.A.;REIMER, RAYLENE;DARIMONT-NICOLAU, CHRISTIAN;MACE, KATHERINE;GREMLICH, SANDRINE;NEESER, JEAN-RICHARD